Empowering life sciences dealmakers in service of patients. https://xitter.gq/t.co/xYbrTqb4Fh
San Francisco, CA
Joined May 2016
- Tweets275
- Following439
- Followers204
- Likes316
motionhall retweeted
That's a wrap for #BIO2019 in Philly!
We can't wait to see you at #BIO2020 in California!
Details: convention.bio.org/2020/
motionhall retweeted
Biogen has lost more value this morning (~$17B) than was raised in all 130+ biotech IPOs since Jan 2015 combined (~$15B)... Ouch. $BIIB
motionhall retweeted
This is the key chart that is on everyone’s mind today. $4.5B invested into US BioPharma by Chinese investors in 2018. How will it be impacted by the new CFIUS rule in 2019? Via Katherine Andersen of SVB. #JPM19
motionhall retweeted
At the @endpts drug pricing panel, @peterbachmd says one problem: we have systematically overemphasized treatments for rare/orphan diseases. #JPM19 – at South San Francisco, CA
motionhall retweeted
Private healthcare venture money still flowing in 2019... First 5 days of January 2019 saw at least ~$1.5B in venture funding announced across 10+ deals. #JPM19
motionhall retweeted
Spoke w/ @RPCraig of @motionhall and Ed Saltzman of Defined Health about the intersection of life sciences and biotech investing.
spreaker.com/user/10197011/r…
breaker.audio/venture-storie…
motionhall retweeted
As @TheEconomist points out, rising #healthcare costs are driven in part by excessive profits made by insurance companies and other drug cost middlemen – all of which do little to reinvest in innovation. buff.ly/2GaPlQf
motionhall retweeted
The @US_FDA has taken many important steps to ensure Americans with rare diseases have access to the medicines they need and deserve. #RareDiseaseDay buff.ly/2FF4WVE
motionhall retweeted
All the decent nuggets of advice in this blog, I learned from others. Big thanks to those that develop & support colleagues, whether as manager, mentor, or friend. Communities, whether physical, corporate, or biotwitter, allow us to grow & improve. So, about that coffee? xitter.gq/LifeSciVC/status/95831…
"So, Your Board Asked For A Deal This Year?" Great BD insight in this From The Trenches blog from #NimbusTx's @JebKeiper lifescivc.com/2018/01/board-…
motionhall retweeted
On the state of #ArtificialIntelligence - "We’re in the late 1800s, Karl Benz just invented the automobile, people are calling it a teleportation machine. We just call it a faster way to get from A to B."
motionhall retweeted
In #sanfrancisco for #jpm18 and #bts18 next week? Join the first #biotechbikers network cycle ride on January 11th. Email [email protected] for details #biotech #SocPharm – at Stockholm, Sweden
motionhall retweeted
The #JPM18 Breakout Brouhaha last week got us thinking: there should be a giant calendar that includes all of the links to all of breakout webcasts. So we're creating one.
It's here: docs.google.com/spreadsheets… (you can help edit!)
More explanation: linkedin.com/pulse/bringing-…
motionhall retweeted
RT'ing a post from 4 years ago "Introducing" Atlas' Biotech Startup Seed Class of 2013. Revisited today with update on progress: lifescivc.com/2017/12/portfo… xitter.gq/LifeSciVC/status/41292…
Introducing Atlas’ Biotech Seed Class of 2013. Sharing snapshot of our new startups and our seed-led strategy lifescivc.com/2013/12/introd…
motionhall retweeted
Less than 20% of 2017 FDA Drug Approvals target novel, first-in-class mechanisms. Trend or blip? @LifeSciVC takes a look at what the implications might be: lifescivc.com/2017/11/search…
motionhall retweeted
Celgene's Michael Pehl leaps up to lead role at Immunomedics; GSK nabs Hal Barron to helm R&D; Aimmune CEO to step down endpts.com/celgenes-michael-… #biotech
motionhall retweeted
George Yancopoulos, pres & CSO of @regeneron on building a biotech to last. Listen to Ep3 of The Long Run podcast-> timmermanreport.com/2017/10/…
motionhall retweeted
I'm Climbing Mt. Everest to Support Cancer Research @fredhutch Watch VIDEO-> timmermanreport.com/2017/10/… DONATE HERE-> engage.fredhutch.org/site/TR…